RCKT

NASDAQStock

Rocket Pharmaceuticals, Inc.

$4.94-0.01 (-0.30%)

52-Week Range

$2.33
$8.83

Key Stats

Market Cap

536.3M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.45

Volume

1.3M

Avg Volume

3.6M

Performance

1M

+51.85%

3M

+44.28%

6M

+52.80%

YTD

+42.20%

1Y

-42.12%

3Y

-73.73%

5Y

-91.33%

Price Chart

ETF Exposure

RCKT is held by 46 ETFs

ETFFund NameWeight
BBCVirtus Biotech Clinical Trials ETF1.16%
WDNAWisdomTree BioRevolution Fund0.46%
JPLDJPMorgan Limited Duration Bond ETF0.30%
GNOMGlobal X - Genomics & Biotechnology ETF0.29%
JCPBJPMorgan Core Plus Bond ETF0.15%
JMTGJPMorgan Mortgage-Backed Securities ETF0.12%
JBNDJPMorgan Active Bond ETF0.11%
JSCPJPMorgan Short Duration Core Plus ETF0.09%
RFLRInnovator U.S. Small Cap Managed Floor ETF0.08%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.06%
FESMFIDELITY ENHANCED SMALL CAP ETF0.05%
IBBiShares Biotechnology ETF0.05%
IBBQInvesco Nasdaq Biotechnology ETF0.04%
BIBProShares - Ultra Nasdaq Biotechnology0.03%
IWNiShares Russell 2000 Value ETF0.03%
RESMColumbia Research Enhanced Small Cap ETF0.02%
VTWVVanguard Russell 2000 Value ETF0.02%
IWMiShares Russell 2000 ETF0.01%
AVSCAvantis U.S. Small Cap Equity ETF0.01%
RSSLGlobal X - Russell 2000 ETF0.01%
SCHASchwab U.S. Small-Cap ETF0.01%
UWMProShares - Ultra Russell20000.01%
DFASDimensional - US Small Cap ETF0.01%
URTYProShares - UltraPro Russell20000.01%
VTWOVanguard Russell 2000 ETF0.01%
VHTVanguard Health Care ETF0.00%
VXFVanguard Extended Market ETF0.00%
SMMDiShares Russell 2500 ETF0.00%
VTWGVanguard Russell 2000 Growth ETF0.00%
HDGProShares - Hedge Replication ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
AVSUAvantis Responsible U.S. Equity ETF0.00%
DFAUDimensional - US Core Equity Market ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%

About RCKT ETF Exposure

Rocket Pharmaceuticals, Inc. (RCKT) is held by 46 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 536.3M, RCKT is a widely held institutional stock. The stock currently trades at $4.94. Investors can gain exposure to RCKT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RCKT, sorted by portfolio weight.